logo
Apple's Wearables Hit Headwinds Amid Weak Upgrades

Apple's Wearables Hit Headwinds Amid Weak Upgrades

Yahoo07-05-2025
Apple's (NASDAQ:AAPL) watch business took a hit last year, with volumes down 19% as North Americastill responsible for over half of all shipmentssaw the biggest slump. Every region except India felt the pinch. Even the high-end Watch Ultra 3, which usually accounts for more than 10% of sales, slipped below 8% in Q4 2024.
On the flip side, the more affordable Watch SE was the top seller right after its launch. Counterpoint Research says the main culprit is that the Series 10 didn't offer enough fresh features to excite buyers, and the wearables market has only gotten more crowded.
Analyst Balbir Singh thinks Apple needs to shake things up in 2025 if it wants to win back customers. He's calling for bold new features, refreshed SE and Ultra lines, and a possible design overhaul.
Since Apple's wearables are a big part of its Services revenue, getting smartwatches back on track matters more than ever. Singh believes a revamped SE and an upgraded Ultra 3 could be just what Apple needs to turn around shipments and get growth back into the green.
Why you should care: Smartwatches are a key growth lever for Apple's ecosystem, so losing ground in North America could hit both revenue forecasts and investor confidenceespecially as rivals step up their own game with new hardware and competitive pricing.
Keep an eye on WWDC in June and early sales reports to see if Apple can reignite interest and bring those shipment numbers back up.
This article first appeared on GuruFocus.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

APA Group (APAJF) (FY25) Earnings Call Highlights: Record EBITDA and Strategic Shifts
APA Group (APAJF) (FY25) Earnings Call Highlights: Record EBITDA and Strategic Shifts

Yahoo

time28 minutes ago

  • Yahoo

APA Group (APAJF) (FY25) Earnings Call Highlights: Record EBITDA and Strategic Shifts

This article first appeared on GuruFocus. Revenue: Not explicitly mentioned in the transcript. EBITDA: FY25 underlying EBITDA up 6.4% to over $2 billion. EBITDA Margin: Expanded to 74.2%. Free Cash Flow: Increased by 1% to approximately $1.1 billion. Net Profit After Tax (NPAT): Excluding significant items, up 8.4%. Distribution: FY25 distribution of $0.57 per security, up $0.01 from last year. FY26 Distribution Guidance: $0.58 per security. FY26 EBITDA Guidance: Between $2.12 billion and $2.2 billion, midpoint represents a 7.2% increase. Cost Reduction Target: Approximately $50 million for FY26. Organic Growth Pipeline: Increased from $1.8 billion to $2.1 billion. Credit Metrics: Improved from 10.1% to 10.4%. Capital Expenditure: Growth CapEx includes Kurri Kurri lateral pipeline and Port Hedland Solar and Battery Projects. Debt Management: Raised USD1.25 billion in US dollar bond market with 10- and 20-year maturities. Warning! GuruFocus has detected 13 Warning Signs with APAJF. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points APA Group (APAJF) reported a 6.4% increase in FY25 EBITDA, reaching over $2 billion for the first time. The company has achieved 21 consecutive years of distribution growth, with FY25 distributions up by $0.01 per security. APA Group has successfully simplified its business by divesting noncore assets and announcing a $50 million cost-out target for FY26. The organic growth pipeline has increased from $1.8 billion to $2.1 billion, with strong momentum in executing strategic projects. The company has improved its credit metrics, with funds from operation to net debt increasing from 10.1% to 10.4%, supporting future growth funding from the existing balance sheet. Negative Points APA Group faced a serious safety incident involving an all-terrain vehicle, highlighting the need for continued vigilance in safety practices. The company has withdrawn from large East Coast electricity transmission projects, which were previously a significant part of its addressable market. Higher interest costs and cash tax payments partially offset the benefits from the uplift in underlying EBITDA. The divestment of the Networks business is expected to reduce FY26 earnings by about $15 million. There is potential volatility in earnings from the Basslink asset, which may impact financial performance in FY26. Q & A Highlights Q: Can you expand on the decision to move away from East Coast electricity transmission projects and what opportunities will fill this gap in your growth outlook? A: Adam Watson, CEO: The strategy remains focused on delivering energy infrastructure supported by long-term contracts and inflation-linked returns. Despite moving away from larger electricity transmission projects, we still have a significant addressable market exceeding $100 billion, focusing on gas transmission, storage, remote grids, and future fuels. Q: Are shippers willing to sign long-term contracts for the East Coast Grid expansion, or will APA need to take on some underwriting risk? A: Adam Watson, CEO: We don't expect the market to fully underwrite projects with long-term contracts as in the past. We've invested significantly in the East Coast grid, taking on market risk, and demand has been strong. We aim to work with customers and the government to secure the necessary confidence for larger investments. Q: How does APA plan to offset the EBITDA decline from the Wallumbilla Gladstone Pipeline capacity tariff expiring? A: Adam Watson, CEO: We are not trying to replace WGP earnings dollar for dollar. Our focus is on continuing to grow the business and delivering returns for shareholders through distribution growth and capital allocation that exceeds our hurdle rate. Q: What is APA's approach to gas power generation (GPG) given the supply chain challenges and emissions targets? A: Adam Watson, CEO: We maintain strong relationships with suppliers to manage supply chain challenges. Our focus is on supporting the energy transition and reducing economy-wide emissions. We are prepared to adjust our intensity targets if necessary, while continuing to bring renewable power generation to market. Q: How does APA view the potential impact of LNG imports on its operations and strategy? A: Adam Watson, CEO: LNG imports are present, but we emphasize the need for market stability to avoid LNG imports setting energy prices, as seen in the UK. Domestic supply is abundant, and regulatory and policy settings should support its development. We focus on ensuring competitive pricing and stability in the market. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Keysight Technologies Inc (KEYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and AI ...
Keysight Technologies Inc (KEYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and AI ...

Yahoo

time28 minutes ago

  • Yahoo

Keysight Technologies Inc (KEYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and AI ...

This article first appeared on GuruFocus. Revenue: $1.4 billion, up 11% year-over-year. Earnings Per Share (EPS): $1.72, exceeding guidance. Orders: Increased by 7% year-over-year. Gross Margin: 64%. Operating Expenses: $526 million. Operating Margin: 25%, up 60 basis points from last year. Net Income: $297 million. Communications Solutions Group Revenue: $940 million, up 11% year-over-year. Electronic Industrial Solutions Group Revenue: $412 million, up 11% year-over-year. Cash Flow from Operations: $322 million. Free Cash Flow: $291 million. Cash and Cash Equivalents: $2.636 billion. Share Repurchase: 300,000 shares at an average price of $164, totaling $50 million. Q4 Revenue Guidance: $1.370 billion to $1.390 billion. Q4 EPS Guidance: $1.79 to $1.85. Warning! GuruFocus has detected 6 Warning Signs with VVOS. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Keysight Technologies Inc (NYSE:KEYS) reported an 11% year-over-year increase in revenue to $1.4 billion, exceeding the high end of their guidance. Orders increased by 7% with growth across both the Communications Solutions Group (CSG) and Electronic Industrial Solutions Group (EISG) segments. The company saw strong growth in aerospace, defense, government, and general electronics, with stability in wireless and automotive sectors. Keysight Technologies Inc (NYSE:KEYS) is capitalizing on AI momentum, with significant investments in AI-related technologies and partnerships, such as with AMD for PCIe Gen 6 compliance validation. The company reported a gross margin of 64% and an operating margin of 25%, with earnings per share of $1.72, up 9% year over year. Negative Points The company is facing challenges with tariffs, which are expected to increase their tariff exposure by approximately $75 million annually. Despite strong performance, the automotive sector remains stable year over year, indicating potential challenges in achieving growth in this segment. The broader 6G commercialization is still years away, which may delay potential revenue from this technology. The company is experiencing headwinds in the semiconductor sector, despite robust demand for wafer test solutions. There are ongoing geopolitical and macroeconomic uncertainties that could impact future performance and market conditions. Q & A Highlights Q: Satish, on past calls, you characterized your expectation for a recovery in the end markets overall as gradual. I don't think I heard you use that word today. Can you help investors understand your view of the end markets now and to what extent it's better than you'd previously expected? A: Strong quarter, clearly, and we're feeling good about the funnel and customer activity despite the overhang from tariffs and geopolitical environment. Order growth has accelerated, and we're feeling slightly better than expected at the beginning of the year. However, not all end markets are up; AI and aerospace defense are strong, while automotive faces challenges. Q: Can you help us better understand what's supporting the revenue outlook into 4Q, given that orders were up high-single digits but the book-to-bill was just below 1? A: Some of this is due to the timing of big deals. We had a large system integration deal accepted on the last day of Q3, which elevated Q3 performance and pulled from Q4. We expect more normal sequential seasonality on the order front than on the revenue front due to the timing of these deals. Q: Neil, as we think about revenue growth and recovery, you mentioned a 5% to 7% top-line growth rate as a long-term model. Is that how we should think about fiscal '26? A: We started the year with a gradual recovery expectation and are now looking at revenue growth at the low end of that range. Things have unfolded slightly better, allowing us to raise expectations. We're bullish going into '26, with caution around tariffs and macroeconomic factors. Q: How do you respond to investors asking about the mix of AI's contribution to the Keysight story, particularly in wireline? A: We're well-positioned for the long-term AI opportunity. AI will contribute across multiple end markets over time. Wireline business is expected to finish strong due to AI demand. It's hard to isolate AI's impact as it involves entrenched ecosystems, but business with us is growing, driven by AI. Q: Can you outline where the tariffs are most substantial for you, and is the mitigation plan focused on moving production or pricing? A: We have a geographically diverse manufacturing footprint, with significant operations in Southeast Asia, the EU, Japan, and the US. Mitigation involves supply chain strategies, possibly shifting manufacturing, and passing costs to customers through price increases and surcharges. We expect to fully mitigate the April tariffs by Q1 and the August increase by the first half of FY26. Q: On aerospace and defense, should we see this market continue to accelerate, or is this a good level due to the time it takes for programs to get into place? A: The starting point for the year was slower, but demand has returned in the second half. Ongoing programs and backlog for prime contractors are robust, indicating a positive environment. The US situation is understood, and European spending could impact long-term growth. Aerospace and defense are steady value creators, though growth may not be as quick as commercial markets. Q: Could you touch on the moving parts around the incremental margin of 40% you talked about? A: The 40% incremental margin is the right long-term target. Tariffs impacted this year's ability to deliver, but once included in the baseline, we can achieve it with mid-single-digit growth. Stripping out tariff impact, we are overachieving the 40% incremental in recent quarters. Q: Can you provide thoughts on customer engagement timelines and when 6G might become a more meaningful revenue contributor? A: Recent 3GPP meetings reinforced industry alignment from 5G to 6G, which is positive for us. Customers are exploring 6G facets, building IP for eventual rollout. While years away from rollout, R&D activity will grow, and we're well-positioned to support this transition. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...
Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...

Yahoo

time28 minutes ago

  • Yahoo

Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...

This article first appeared on GuruFocus. Total Revenue (H1 2025): $3.2 million, up from $2.3 million in H1 2024. Research and Development Expenses (H1 2025): $4.8 million, down from $6.5 million in H1 2024. Sales and Marketing Expenses (H1 2025): $800,000, down from $1.1 million in H1 2024. Total Operating Expenses (H1 2025): $7.7 million, down from $11.1 million in H1 2024. Cash and Short-term Bank Deposits (End of H1 2025): $11.7 million. Operating Loss (H1 2025): $6.1 million, down from $9.4 million in H1 2024. Net Loss (H1 2025): $7.7 million, down from $9.8 million in H1 2024. Cash Usage (Q2 2025): $2.4 million. Financing Income (H1 2025): $732,000, up from $373,000 in H1 2024. Loss from Operations Held for Sale, Net (H1 2025): $2.2 million, up from $0.8 million in H1 2024. Warning! GuruFocus has detected 6 Warning Signs with EVGN. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Evogene Ltd (NASDAQ:EVGN) reported an increase in total revenues for the first half of 2025 to approximately $3.2 million, up from $2.3 million in the first half of 2024, driven by strong seed sales from its subsidiary Casterra. The company executed a cost reduction plan, resulting in a significant decrease in operating expenses, with total operating expenses net for the first half of 2025 at approximately $7.7 million compared to $11.1 million in the same period last year. Evogene Ltd (NASDAQ:EVGN) completed the sale of Lavie Bio's assets and the MicroBoost AI for Ag tech-engine to ICL, generating significant cash flow and enhancing the company's financial position. The company is focusing on maximizing the value of its ChemPass AI platform, which has been strengthened by the completion of the GeneRator AI foundation model developed in collaboration with Google Cloud. Evogene Ltd (NASDAQ:EVGN) successfully raised $4.4 million through its ATM facility, providing a solid financial foundation and operational runway of approximately 18 months. Negative Points Evogene Ltd (NASDAQ:EVGN) is undergoing a strategic shift, which includes significant organizational changes and workforce reductions, potentially impacting employee morale and operational stability. The company reported a net loss for the first half of 2025 of approximately $7.7 million, although this was a decrease from the $9.8 million loss in the same period last year. There is uncertainty regarding the commercialization of Casterra's castor seed inventory, as the company is exploring options to sell seeds directly or grow and sell grain. The ongoing geopolitical situation in Israel, including the conflict with Hamas and Hezbollah, poses risks and uncertainties that could affect the company's operations and financial performance. Evogene Ltd (NASDAQ:EVGN) faces challenges in achieving peak sales and establishing new partnerships, particularly in the pharma and agriculture sectors, which are crucial for future growth. Q & A Highlights Q: How much castor seed inventory does Evogene have, and what are the plans if the current customer does not place a follow-on order? A: Ofer Haviv, President and CEO, stated that while he won't disclose specific inventory amounts, Evogene has a few hundred tons of Casterra seed ready for sale. The company plans to sell these seeds to partners or use them to grow grain through subcontractors, as they have a better understanding of cultivation in certain territories. Initial results from trials in Brazil and Kenya are promising. Q: What steps need to occur before Evogene can announce a castor oil business? A: Ofer Haviv explained that Evogene is currently focused on grain cultivation and selling grain to partners. There is significant demand from oil factories in Africa and Brazil. The main challenge is the cost of growing castor, which Evogene aims to address with its unique variety and growth protocols. Q: The stock is still low. When will it start going up? A: Ofer Haviv mentioned that while the stock market is unpredictable, Evogene is finalizing a new company presentation and website to reflect its strategy. The company plans to announce new collaborations in pharma and agriculture, which should strengthen its value proposition and potentially impact the stock positively. Q: How representative are operating expenses in Q2 2025, and are all cost reductions fully reflected? A: Ofer Haviv confirmed that the third and fourth quarters are expected to show continued declines in expenses across R&D, marketing, and G&A, reflecting the full impact of cost reductions. Q: What was revenue in Q2 '25, and how should we think about peak sales? A: Ofer Haviv noted that Casterra is currently the only activity producing regular sales, primarily from seed sales. The company is in discussions with multiple partners to expand castor oil activities, focusing on reducing cultivation costs to maximize yield versus expenses. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store